KFP
AGIO icon

KB Financial Partners’s Agios Pharmaceuticals AGIO Stock Holding History

KB Financial Partners’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-418
Closed -$23K – 174
2021
Q2 		$23K Sell
418
-50
-11% -$2.8K 0.01% 335
2021
Q1 		$24K Buy
+468
New +$23.2K 0.01% 336

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

KB Financial Partners's AGIO Position: Q3 2021 in Review

KB Financial Partners sold out of Agios Pharmaceuticals (AGIO) in Q3 2021, closing a stake of 418 shares — an estimated $23K sold.

KB Financial Partners first reported a position in AGIO in Q1 2021 and held it in 2 quarters. The position peaked at $24K in Q1 2021. 164 funds tracked by Wall St. Rank hold AGIO as of Q3 2021.

  • KB Financial Partners reported no remaining Agios Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • KB Financial Partners sold 418 Agios Pharmaceuticals shares in Q3 2021, an estimated $23K.
  • KB Financial Partners first reported a position in Agios Pharmaceuticals in Q1 2021 and held it in 2 quarters.
  • KB Financial Partners's Agios Pharmaceuticals position peaked at $24K in Q1 2021.
  • 164 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2021.

Based on KB Financial Partners's 13F filing for Q3 2021, filed 16 Nov 2021.